Recent Quotes
My Watchlist
Indicators
OGJ 150 Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Genexa

News headline image
Genexa, the First-Ever Clean Medicine Brand, Releases State of the Sick Day Study, Revealing What Parents Actually Face When Their Kids Get Sick
From Genexa
Via Business Wire
News headline image
New Survey Reveals Pediatricians Overwhelmingly Prefer Genexa’s Ingredients Over Children’s Tylenol® Leading Products
From Genexa
Via Business Wire
News headline image
Genexa Launches Clean Line of Kids’ Medicine in Whole Foods Market
From Genexa
Via Business Wire
News headline image
Genexa Launches New Clean Cough & Cold Medicines for Kids
From Genexa
Via Business Wire
News headline image
Genexa Launches New Organic Flavor of Their Best-Selling Kids’ Medicine
From Genexa
Via Business Wire
News headline image
Genexa Receives Its First Patent for Agave-Based Medicines
From Genexa
Via Business Wire
News headline image
Genexa Provides Clean and Effective Infants’ and Kids’ Pain and Fever Reducers in Light of Impending Shortages
From Genexa
Via Business Wire
News headline image
Genexa Introduces New Cough & Chest Congestion Medicine for Adults, Providing Consumers With a Clean, Effective Choice for Cold & Flu Season
From Genexa
Via Business Wire
News headline image
Genexa® Launches the First Ever Clean Acetaminophen Pain Relief Products for Adults
From Genexa
Via Business Wire
News headline image
Genexa, the First and Only Clean Medicine Company Appoints Chief Marketing Officer
From Genexa
Via Business Wire
News headline image
Pediatricians Prefer Genexa’s Kids’ Pain & Fever Medicine Over Its Primary Competitor’s Product for Treating Their Own Children
From Genexa
Via Business Wire
News headline image
Genexa, the World’s First and Only Clean Medicine Company, Announces Record-breaking Series A Round
From Genexa
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>